Latest news and press releases

Bracco Announces $230 Million Investment in First U.S. Manufacturing Facility for Injectable Contrast Media

28 October 2026

buttare

Major Global Milestone with U.S. FDA 510(k) Clearance and Health Canada Authorization for for VueJect®, the First Dedicated Ultrasound Contrast Delivery System

11 August 2026

Bracco Vueject: ultrasound contrast delivery system

Bracco Launches BubbleGen™ Early Access Program for Microbubble-Based Cell Selection and Activation at ISCT

05 May 2026

Bubbles

Bracco Imaging and NYU Langone Health Announce Strategic Alliance Agreement to Advance Medical Imaging Innovation

20 April 2026

A handshake between two businessmen

Bracco Invests in GMP Manufacturing Facility for Cell Therapy Product

31 March 2026

Bracco GMP Manufacturing Facility

Bracco Enters Cell Therapy Manufacturing with Cell Selection and Activation Technologies 

04 February 2026

Bracco Geneva Site

The European Commission extended the Marketing Authorisation for VUEWAY® (gadopiclenol) in the European Union for use in pediatric patients under 2 years of age

27 January 2026

The CHMP adopted a positive opinion for gadopiclenol use in pediatric patients under 2

Press kit

Media contacts

If you are a journalist and you need more information about Bracco Imaging Group.

 

Bracco Imaging S.p.A.

Media Relations

Via Egidio Folli 50, 20134 - Milan, Italy

 

Tel. +39 (02) 21772279

Contact by email: [email protected]

Contact us


Please fill out the form below and we will get back to you

* I have read the BraccoHealthCare Professionals Privacy Notice and I consent to the processing of my personal data allowing Bracco Imaging SpA (Data Controller) to conduct its business or scientific operations and contact me with promotional communication through email, SMS, and other digital and offline channels, such as mobile apps and social media.

Different countries may have specific processes in place to handle reports of adverse reactions. To report an adverse reaction related to Bracco products, you can find specific contacts and information selecting the page "Pharmacovigilance" of your country.